1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/124030
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGarland, Suzanne M.-
dc.contributor.authorBrotherton, J. M. L.-
dc.contributor.authorMoscicki, Anna-Barbara-
dc.contributor.authorKaufmann, A. M.-
dc.contributor.authorStanley, Margaret-
dc.contributor.authorBhatla, N.-
dc.contributor.authorSankaranarayanan, Rengaswamy-
dc.contributor.authorSanjosé Llongueras, Silvia de-
dc.contributor.authorPalefsky, Joel-
dc.date.accessioned2018-07-27T12:01:22Z-
dc.date.available2018-07-27T12:01:22Z-
dc.date.issued2017-12-01-
dc.identifier.urihttp://hdl.handle.net/2445/124030-
dc.description.abstractIt is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.-
dc.format.extent4 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1016/j.pvr.2017.06.002-
dc.relation.ispartofPapillomavirus Research, 2017, vol. 4, p. 35-38-
dc.relation.urihttp://dx.doi.org/10.1016/j.pvr.2017.06.002-
dc.rightscc by-nc-nd (c) Garland et al., 2017-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/-
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationVacuna del papil·lomavirus-
dc.subject.otherPapillomavirus vaccines-
dc.titleHPV vaccination of immunocompromised hosts-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2018-07-24T11:53:24Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29179867-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
GarlandSM.pdf237.86 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons